EN
HI
Summary
As of 20 Oct, 2026, Mankind Pharma stock price is ₹2253.2. During the trading session, the stock has moved between an intraday low of ₹2246.00 and an intraday high of ₹2348.50. Over the last 52 weeks, Mankind Pharma has traded between ₹1909.70 and ₹2642.00.
The stock has recorded a trading volume of 12,28,705 shares,. Its Average Traded Price (ATP) is ₹2288.78, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 36 @ ₹2253.20.
Mankind Pharma has an upper circuit limit of ₹2503.00 and a lower circuit limit of ₹2048.00. The total value traded stands at ₹281.22 CR, and the delivery percentage for the day is 61.71%.
The stock is currently traded with a market lot size of 1. Mankind Pharma also offers a dividend yield of 0.04%.
Mankind Pharma Share Price Chart
Mankind Pharma Share Key Metrics
Volume
12.29 L
Market Cap
93067.32 CR
LTQ@LTP
36@2253.20
ATP
2288.78
Var Margin
14.66 %
Circuit Range
2048-2503
Delivery %
61.71 %
Value
281.22 CR
ASM/GSM
No
Market Lot
1
Mankind Pharma Fundamentals
P/E Ratio
46
P/B Ratio
5.58
Div. Yield
0.04
Sector P/E
40.5
Sector P/B
3.4
Sec. Div. Yield
0.52
Mankind Pharma Resistance and Support
Pivot 2299.53
Resistance
First Resistance
2330.36
Second Resistance
2385.23
Third Resistance
2416.06
Support
First Support
2244.66
Second Support
2213.83
Third Support
2158.96
Mankind Pharma Futures & Options
Mankind Pharma Option Chain
View Price, OI, Greeks & More...
27OCT26
2260.70
-22.50 (0.99%)
23NOV26
2258.00
-23.40 (1.03%)
29DEC26
2260.00
-25.00 (1.09%)
MANKIND|27OCT26 CE 2240.00
0.00
-443.15 (-100%)
MANKIND|27OCT26 PE 2260.00
46
10.45 (29.4%)
Mankind Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 19 2026 | 2264.1 | 2253.2 | -0.98% | 2348.5 | 2246 |
| Fri Oct 16 2026 | 2349.89 | 2275.5 | -3.07% | 2354.39 | 2268.69 |
| Thu Oct 15 2026 | 2325.6 | 2347.6 | 0.54% | 2365 | 2321.1 |
Mankind Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-26 | Quarterly Results |
| 2026-07-30 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-31 | Quarterly Results & Interim Dividend |
| 2025-05-21 | Audited Results |
| 2025-01-23 | Quarterly Results |
| 2024-11-05 | Quarterly Results |
Mankind Pharma News
Mankind Pharma Ltd - 543904 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Mankind Pharma successfully redeemed NCDs worth Rs.1,250 crores on maturity. The company also completed half-yearly interest payments for two NCD issues totaling Rs.3,750 crores.
Oct 16 2026 17:04:12
Mankind Pharma Ltd - 543904 - Board Meeting Outcome for Outcome Of Board Meeting
Mankind Pharma will acquire a 70% stake in Belgium-based Armed Cell Therapeutics for EUR 48 million. The strategic investment made via its Netherlands subsidiary marks the company's entry into next-generation CAR-T cancer therapies.
Oct 15 2026 19:23:55
Read More
Mankind Pharma Management
| Name | Position |
|---|---|
| Hitesh Kumar Jain | Company Secretary & Compliance Officer |
| Ramesh Juneja | Chairman |
Mankind Pharma Similar Stocks
Zydus Lifesciences Ltd.
1113.90
-9.10 (0.81%)
Lenskart Solutions Ltd.
639.95
-6.55 (1.01%)
Laurus Labs Ltd.
2069.00
8.90 (0.43%)
Cipla Ltd.
1324.10
-1.00 (0.08%)
Dr. Reddy's Laboratories Ltd.
1242.50
9.50 (0.77%)
Aurobindo Pharma Ltd.
1621.40
-45.50 (2.73%)
Lupin Ltd.
1939.20
-22.40 (1.14%)
Manipal Health Enterprises Ltd.
630.05
-12.35 (1.92%)
Max Healthcare Institute Ltd.
830.00
-16.00 (1.89%)
Glenmark Pharmaceuticals Ltd.
2210.20
-16.50 (0.74%)
Mankind Pharma FAQs
The Buying Price of Mankind Pharma share is 2253.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Mankind Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Mankind Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Mankind Pharma shares is 46. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Mankind Pharma shares is 5.58. Useful to assess the stock's value relative to its book value.
To assess Mankind Pharma’s valuation compare Sector P/E, P/B which are 40.5 & 3.4 with sector averages, along with growth rates and financial metrics.
The Market Cap of Mankind Pharma is 93067.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Mankind Pharma share price is 2642.00 & 1909.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Mankind Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in MANKIND
